“I’ve never understood why men don’t talk about it. A couple of men I know who had prostate cancer, as far as them coming together — nobody talks about it. There are times men are bragging, you know, on this subject, but now it’s just total silence,” says “Joe” (not his real name) of Oxnard,.. read more →

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid, Spain. Read more read more →

DEAR MAYO CLINIC: At what age should I be screened for prostate cancer? I have read different things about the best time to first have it done. Read more read more →

A new imaging technique called oxygen enhanced optoacoustic tomography (OE-OT) may improve the ability to distinguish between aggressive and less-aggressive prostate cancer cases, identifying those patients who can undergo chemo and/or radiation therapy, according to researchers. Read more  read more →

Finding a robust positive predictive biomarker for immunomodulatory drugs is difficult, says Charles Drake, MD, PhD, as the immune tumor microenvironment is so complex. Read more read more →